These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17565006)

  • 21. Deletion of cd39/entpd1 results in hepatic insulin resistance.
    Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
    Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
    Aldi S; Marino A; Tomita K; Corti F; Anand R; Olson KE; Marcus AJ; Levi R
    FASEB J; 2015 Jan; 29(1):61-9. PubMed ID: 25318477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
    Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
    Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
    Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration.
    Färber K; Markworth S; Pannasch U; Nolte C; Prinz V; Kronenberg G; Gertz K; Endres M; Bechmann I; Enjyoji K; Robson SC; Kettenmann H
    Glia; 2008 Feb; 56(3):331-41. PubMed ID: 18098126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of cochlear function in Cd39 deficient mice.
    Vlajkovic SM; Housley GD; Thorne PR; Gupta R; Enjyoji K; Cowan PJ; Charles Liberman M; Robson SC
    Hear Res; 2009 Jul; 253(1-2):77-82. PubMed ID: 19327391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.
    Braun N; Sévigny J; Robson SC; Enjyoji K; Guckelberger O; Hammer K; Di Virgilio F; Zimmermann H
    Eur J Neurosci; 2000 Dec; 12(12):4357-66. PubMed ID: 11122346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional evidence for purinergic inhibitory neuromuscular transmission in the mouse internal anal sphincter.
    McDonnell B; Hamilton R; Fong M; Ward SM; Keef KD
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1041-51. PubMed ID: 18308858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic activation of astrocytes by ATP and norepinephrine in the rat supraoptic nucleus.
    Espallergues J; Solovieva O; Técher V; Bauer K; Alonso G; Vincent A; Hussy N
    Neuroscience; 2007 Sep; 148(3):712-23. PubMed ID: 17693027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
    Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
    Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA release by basket cells onto Purkinje cells, in rat cerebellar slices, is directly controlled by presynaptic purinergic receptors, modulating Ca2+ influx.
    Donato R; Rodrigues RJ; Takahashi M; Tsai MC; Soto D; Miyagi K; Villafuertes RG; Cunha RA; Edwards FA
    Cell Calcium; 2008 Dec; 44(6):521-32. PubMed ID: 18468677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic dysregulation in pulmonary hypertension.
    Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
    Hyman MC; Petrovic-Djergovic D; Visovatti SH; Liao H; Yanamadala S; Bouïs D; Su EJ; Lawrence DA; Broekman MJ; Marcus AJ; Pinsky DJ
    J Clin Invest; 2009 May; 119(5):1136-49. PubMed ID: 19381014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system.
    Braun N; Sévigny J; Robson SC; Hammer K; Hanani M; Zimmermann H
    Glia; 2004 Jan; 45(2):124-32. PubMed ID: 14730706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP signaling is crucial for communication from taste buds to gustatory nerves.
    Finger TE; Danilova V; Barrows J; Bartel DL; Vigers AJ; Stone L; Hellekant G; Kinnamon SC
    Science; 2005 Dec; 310(5753):1495-9. PubMed ID: 16322458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction.
    Novitskaya T; Nishat S; Covarrubias R; Wheeler DG; Chepurko E; Bermeo-Blanco O; Xu Z; Baer B; He H; Moore SN; Dwyer KM; Cowan PJ; Su YR; Absi TS; Schoenecker J; Bellan LM; Koch WJ; Bansal S; Feoktistov I; Robson SC; Gao E; Gumina RJ
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1244-H1261. PubMed ID: 36240436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
    Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
    FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension.
    Helenius MH; Vattulainen S; Orcholski M; Aho J; Komulainen A; Taimen P; Wang L; de Jesus Perez VA; Koskenvuo JW; Alastalo TP
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1046-57. PubMed ID: 25820525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD39 modulates IL-1 release from activated endothelial cells.
    Imai M; Goepfert C; Kaczmarek E; Robson SC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.